Grade Post Therapy Clin (yc) (Brain (V9 2023+))
Organization | Field Name | ID# | ID Name | Required |
---|---|---|---|---|
KCR | Grade Post Therapy Clin (yc) | 30141 | GradePostTherapyClin | yes |
SEER | Grade Post Therapy Clin (yc) | gradePostTherapyClin | yes |
Note 1 Leave Grade Post Therapy Clin (yc) blank when
No neoadjuvant therapy
Clinical or pathological case only
Neoadjuvant therapy completed, no microscopic exam is done prior to surgery/resection of primary tumor
There is only one grade available, and it cannot be determined if it is clinical, pathological, post therapy clinical or post therapy pathological
Note 2 Assign the highest grade from the microscopically sampled specimen of the primary site following neoadjuvant therapy or primary systemic/radiation therapy.
Note 3 If there are multiple tumors with different grades abstracted as one primary, code the highest grade.
Note 4 Codes 1-4 take priority over A-D, L and H.
Note 5 CNS WHO classifications use a grading scheme that is a "malignancy scale" ranging across a wide variety of neoplasms rather than a strict histologic grading system that can be applied equally to all tumor types.
Code the WHO grading system for selected tumors of the CNS as noted in the AJCC 8th edition Table 72.2 when WHO grade is not documented in the record
+ A list of the histologies that have a default grade can also be found in the Brain/Spinal Cord CAP Protocol in Table 1 WHO Grading System for Some of the More Common Tumors of the CNS, Table 2 WHO Grading System for Diffuse Infiltrating Astrocytomas and Table 3 WHO Grading Meningiomas
https//www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templatesFor *benign tumors ONLY (behavior 0), * code 1 can be automatically assigned for all histologies
+ This was confirmed by the CAP Cancer Committee
Note 6 Code 9 (unknown) when
Microscopic exam is done after neoadjuvant therapy and grade from the primary site is not documented
Microscopic exam is done after neoadjuvant therapy and there is no residual cancer
Grade checked “not applicable” on CAP Protocol (if available) and no other grade information is available
Code | Description |
---|---|
1 | WHO Grade I : Circumscribed tumors of low proliferative potential associated with the possibility of cure following resection |
2 | WHO Grade II: Infiltrative tumors with low proliferative potential with increased risk of progression or recurrence |
3 | WHO Grade III: Tumors with histologic and/or molecular genetic evidence of malignancy that are associated with an aggressive clinical course |
4 | WHO Grade IV: Tumors with histologic and/or molecular genetic evidence of malignancy that are associated with the most aggressive clinical course and shorter overall survival |
L | Stated as "low grade" NOS |
H | Stated as "high grade" NOS |
A | Well differentiated |
B | Moderately differentiated |
C | Poorly differentiated |
D | Undifferentiated, anaplastic |
9 | Grade cannot be assessed (GX); Unknown |
<BLANK> | See Note 1 |